erythematosus

Roland Magnusson/iStock Editorial via Getty Images BenevolentAI (OTC:BAIVF) Tuesday said that AstraZeneca (NASDAQ:AZN) has added a novel target for systemic lupus erythematosus to its discovery portfolio through its collaboration with the company. This is the second target to be selected this year from the extended collaboration with AstraZeneca (AZN), highlightingContinue Reading